[Federal Register Volume 76, Number 206 (Tuesday, October 25, 2011)]
[Notices]
[Pages 66069-66070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-27588]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60-Day-12-12AG]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Catina Conner, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    HIV Prevention Among Latino MSM: Evaluation of a Locally Developed 
Intervention--New--National Center for HIV/AIDS, Viral Hepatitis, STD, 
TB Prevention (NCHHSTP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    Latinos are the largest and fastest growing ethnic minority group 
in the U.S. and have the second highest rate of HIV/AIDS diagnoses of 
all racial/ethnic groups in the country. From the beginning of the 
epidemic through 2007, Latinos accounted for 17% of all AIDS cases 
reported to the CDC. Among Latino males, male-to-male sexual contact is 
the single most important source of HIV infection, accounting for 46% 
of HIV infections in U.S.-born Latino men from 2001 to 2005, and for 
more than one-half of HIV infections among South American, Cuban, and 
Mexican-born Latino men in the U.S. (CDC, 2007a; 2007b). In 2006, male-
to-male sex accounted for 72% of new HIV infections among Latino males. 
Relative to other men who have sex with men (MSM), the rate of HIV 
infection among Latino MSM is twice the rate recorded among whites 
(43.1 vs. 19.6 per 100,000).
    Despite the high levels of infection risk that affect Latino MSM, 
no efficacious interventions to prevent infection by HIV and other 
sexually transmitted diseases (STDs) are available for this vulnerable 
population. CDC's Prevention Research Synthesis group, whose role is to 
identify HIV prevention interventions that have met rigorous criteria 
for demonstrating evidence of efficacy, has not identified any 
behavioral interventions for Latino MSM that meet current efficacy 
criteria, and no such interventions are listed in CDC's 2011 update of 
its Compendium of Evidence-Based HIV Behavioral Interventions (http://www.cdc.gov/hiv/topics/research/prs/compendium-evidence-based-interventions.htm). There is an urgent need for efficacious, culturally 
congruent HIV/STD prevention interventions for Latino MSM.
    The purpose of this project is to test the efficacy of an HIV 
prevention intervention for reducing sexual risk among Latino men who 
have sex with men in North Carolina. The HOLA en Grupos intervention is 
a Spanish-language, small-group, 4-session intervention that is 
designed to increase consistent and correct condom use and HIV testing 
among Latino MSM and to affect other behavioral and psychosocial 
factors that can increase their vulnerability of HIV/STD infection. 
This study will use a randomized controlled trial design to assess the 
efficacy of the HOLA en Grupos intervention compared to a general 
health comparison intervention.
    CDC is requesting approval for a 3-year clearance for data 
collection. The data collection system involves screening of potential 
study participants for eligibility, collection of participants' contact 
information, and measures of intervention and comparison participants' 
socio-demographic characteristics, health seeking actions, HIV/STD and 
substance use-related risk behaviors, and psychosocial factors at 
baseline before intervention delivery and 6 months after intervention 
delivery. An estimated 350 men will be screened for eligibility in 
order to enroll the 300 men required for the study. The baseline and 
the 6-month follow-up assessments will be similar. However, the 6-month 
assessment will ask study participants fewer questions because there is 
no need to ask all questions during both assessments. Collection of 
eligibility information from potential participants will require about 
10 minutes; collection of baseline assessment information and 
participant contact information will require about 1 hour and 45 
minutes; and collection of the 6-month follow-up assessment information 
will require about 1 hour.
    There is no cost to participants other than their time.

--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                           Number       Average burden     Total annual
               Type of respondent                             Form name                 Number of      responses per    per respondent      burden in
                                                                                       respondents       respondent       (in hours)          hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Prospective Study Participant..................  Participant Screening Form........              350                1          10/60                  58

[[Page 66070]]

 
Enrolled Study Participant.....................  Baseline Assessment...............              300                1              1.75              525
Enrolled Study Participant.....................  6-month follow-up assessment......              300                1              1                 300
                                                                                    --------------------------------------------------------------------
Total..........................................  ..................................  ...............  ...............  ................              883
--------------------------------------------------------------------------------------------------------------------------------------------------------


Catina Conner,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2011-27588 Filed 10-24-11; 8:45 am]
BILLING CODE 4163-18-P